drugset / Trial / NCT01179854

Remegal Different Doses in Patients With Refractory Partial Seizures

NCT01179854 ↗

Phase 2 Completed 60 enrolled Valexfarm
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine weather different doses of Remegal are effective,safety and tolerant in Additional Therapy for Patients With Refractory Partial Seizures and pharmacokinetics definition

Timeline

Start
2009-09
Primary completion
2010-11
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Remegal Unknown 500 mg —
Subject Remegal Unknown 750 mg —
Subject Remegal Unknown 1000 mg —

Indications

No indication recorded.